Who owns ENVVENO MEDICAL?

Tip: Access positions for across all investors

Analyze quarterly positions in Envveno Medical with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Envveno Medical stock

Who bought or sold ENVVENO MEDICAL this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Nantahala Capital Management 706k $3.6M 100% Dec 2023
 View chart
Perceptive Advisors 623k $3.2M -20% Dec 2023
 View chart
Kingdon Capital Management 619k $3.2M 182% Dec 2023
 View chart
Vanguard Group 336k $1.7M 0% Dec 2023
 View chart
Rosalind Advisors 312k $1.6M 100% Dec 2023
 View chart
Citadel Advisors 69k $353k 100% Dec 2023
 View chart
Fermata Advisors 23k $126k 42% Mar 2024
 View chart
Dimensional Fund Advisors 18k $94k 0% Dec 2023
 View chart
Marshall Wace 15k $79k 100% Dec 2023
 View chart
Tamar Securities 14k $72k 0% Dec 2023
 View chart
Advisor Group Holdings 11k $58k 0% Dec 2023
 View chart
Westside Investment Management 3.8k $20k 100% Mar 2024
 View chart
Wells Fargo & Company 2.1k $11k 1% Dec 2023
 View chart
Royal Bank of Canada 100.00 $1.0k 122% Dec 2023
 View chart
Bank of America Corporation 8.00 $41.000000 100% Dec 2023
 View chart
UBS Group 1.00 $5.000000 0% Dec 2023
 View chart

Who sold out of Envveno Medical?

Fund or Company Name Date Sold Shares Held Valued At
Simplex Trading Sep 2023 18k $95k
Arthur M. Cohen & Associates Dec 2023 14k $72k
Financial Perspectives Dec 2023 3.3k $17k
Newbridge Financial Services Group Sep 2023 20.00 $108.000000
Jpmorgan Chase & Co Sep 2023 11.00 $58.999600